Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Total 13F shares
-
2,351,773
-
Share change
-
+22,409
-
Total reported value
-
$54,907,880
-
Price per share
-
$23.35
-
Number of holders
-
53
-
Value change
-
+$671,304
-
Number of buys
-
27
-
Number of sells
-
28
Institutional Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q1 2019
As of 31 Mar 2019,
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,351,773 shares.
The largest 10 holders included
Maxim Capital Management LLC, AlphaStar Capital Management, LLC, MORGAN STANLEY, Eqis Capital Management, Inc., BOSTON ADVISORS LLC, CABOT WEALTH MANAGEMENT INC, LINCOLN NATIONAL CORP, Sowell Financial Services LLC, BANK OF AMERICA CORP /DE/, and STIFEL FINANCIAL CORP.
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.